Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,720.30
-0.28%
DAX
26,338.61
-0.38%
CAC 40
8,579.60
-0.66%
STOXX 50
6,530.45
-0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 11 May 2021 2:34 pm

EU demands 120m AstraZeneca jabs by end of June as second legal case begins

By: Damian Shepherd

Add as a preferred source on Google
Results from the drug's Phase III trial show a "statistically significant and highly clinically meaningful improvement" in progression-free survival.
Results from the drug's Phase III trial show a "statistically significant and highly clinically meaningful improvement" in progression-free survival. (Photo by Christopher Furlong/Getty Images)

The European Union wants AstraZeneca to deliver at least 120m vaccine doses by the end of June, a lawyer representing the EU said today.

EU lawyer Rafael Jafferali spoke in a Belgian court as proceedings started in the second legal case against AstraZeneca over delayed supplies.

The pharma firm had originally agreed to deliver the EU 300m doses by the end of June but has so far delivered only 50m.

Officials close to the case said the lawsuit would allow the EU to seek possible financial penalties.

The level of compensation for what the EU deems a breach of contract by AstraZeneca will be decided at a later stage.

An AstraZeneca lawyer complained in court that the EU’s executive had launched a second case given that one had already been opened.

Jafferali said the firm should deliver 120m doses by the end of next month in the first formal request made so far by Brussels on the exact volume it wants to receive.

The bloc hopes to collect the remainder of the contracted 300m doses by September.

It was agreed at today’s proceedings that the first hearing in the new case would be on 24 September.

Another hearing has already been set for 26 May on the first legal case in which the EU is seeking an immediate acceleration in deliveries, with a verdict expected before the end of June.

Read more

Astrazeneca explores $400bn megadeal with US rival 

AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • AstraZeneca
  • Company

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca and Jaguar Land Rover given power to endorse talented migrants for visas

    Politics
    Jonathan Reynolds addressing the SMMT's annual International Automotive Summit (image courtesy of SMMT)
  • Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

    Business Wire
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Sainsbury’s to sell Argos in £120m cut-price deal

    Retail
    Sainsburys supermarket entrance with prominent Argos and Lloyds Pharmacy signs, reflecting the companys acquisitions.
  • As it happened: UK stocks cool after Astrazeneca drags; Trump and Iran clash over peace talks

    FTSE 100 Live
    Donald Trump speaking at a desk, gesturing with hands, wearing a dark suit and red tie.
  • As it happened: Stocks fall as oil creeps up; Trump to ‘finish job’ in Iran

    Markets
    Donald Trump speaking at the PAAP office conference, addressing key political issues and strategies in a formal setting.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook